New hope for migraine sufferers: drug works when others fail
NCT ID NCT06701526
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 23 times
Summary
This study tests whether eptinezumab can reduce migraine days and improve quality of life in 150 adults who have migraines at least 8 days per month and did not get enough relief from previous CGRP-targeting therapies. Participants receive the drug and report changes in symptoms and daily functioning over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Neurology of Colorado, LLC
Longmont, Colorado, 80501, United States
-
Albany Medical College
Albany, New York, 12230, United States
-
Brainstorm Research
Miami, Florida, 33176, United States
-
C7 Research
Cleveland, Ohio, 44109, United States
-
Chicago Headache Center & Research Institute
Chicago, Illinois, 60657, United States
-
Crescent City Headache and Neurology
New Orleans, Louisiana, 70115, United States
-
Dent Neurosciences Research Center, Inc.
Amherst, New York, 14226, United States
-
Hasbani & Hasbani MDs
New Haven, Connecticut, 06511, United States
-
Inova Health Care Services
Fairfax, Virginia, 22031, United States
-
KCA Neurology, PLLC
Franklin, Tennessee, 37067, United States
-
Mass Institute of Clinical Research
Westborough, Massachusetts, 01581, United States
-
MedVadis Research Corporation
Watertown, Massachusetts, 02472-3930, United States
-
Memorial Healthcare
Owosso, Michigan, 48867, United States
-
NeuroScience Research Center, LLC.
Canton, Ohio, 44718, United States
-
Neurology Center of New England P.C.
Foxborough, Massachusetts, 02035, United States
-
Neuropain Medical Center
Fresno, California, 93710, United States
-
New England Institute for Neurology and Headache
Stamford, Connecticut, 06905, United States
-
North Suffolk Neurology
Port Jefferson Station, New York, 11776, United States
-
PANDA Neurology and Atlanta Headache Specialists
Atlanta, Georgia, 30328, United States
-
Preferred Primary Care Physicians, Inc.
Pittsburgh, Pennsylvania, 15236, United States
-
Premiere Research Institute at Palm Beach Neurology
West Palm Beach, Florida, 33407, United States
-
Research of the Rockies
Parker, Colorado, 80138, United States
-
St Luke's Meridian Medical Center
Meridian, Idaho, 83642, United States
-
St. Joseph's Hospital and Medical Center - Barrow Neurological Institute
Aurora, Colorado, 80045, United States
-
Sunwise Clinical Research, LLC.
Oakland, California, 94596, United States
-
Texas Neurology, PA
Dallas, Texas, 75206-5202, United States
-
The Neuron Clinic
San Marcos, California, 92069, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.